Webseiten-Bericht für pharmaphorum.com
pharmaphorum | News & views on pharma and biotech’s evolving future
Generiert am 06 März 2026 13:56 PM
Aktuelle Statistiken? UPDATE !
Der Wert ist 56/100
SEO Inhalte
Seitentitel
pharmaphorum | News & views on pharma and biotech’s evolving future
Länge : 67
Perfekt, denn Ihr Seitentitel enthält zwischen 10 und 70 Anzahl Zeichen.
Seitenbeschreibung
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Länge : 158
Großartig, denn Ihre Seitenbeschreibung enthält zwischen 70 und 160 Anzahl Zeichen.
Suchbegriffe
Nicht so gut. Wir konnten keine META-Suchbegriffe auf Ihrer Webseite finden. Benutzen Sie dieses kostenlose Werkzeug um META-Suchbegriffe zu erzeugen.
Og META Eigenschaften
Sehr gut, denn diese Webseite nutzt die Vorteile aus den Og Properties.
| Eigenschaft | Inhalt |
|---|---|
| site_name | pharmaphorum |
| url | https://pharmaphorum.com/homepage |
| title | pharmaphorum| News & views on pharma and biotech’s evolving future |
| description | Pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future. |
Überschriften
| H1 | H2 | H3 | H4 | H5 | H6 |
| 0 | 7 | 37 | 0 | 12 | 0 |
- [H2] Featured Content
- [H2] Latest News
- [H2] Views & Analysis
- [H2] Deep Dive
- [H2] White Papers & Webinar
- [H2] Podcasts & Video
- [H2] Partner Content
- [H3] China's clears Pfizer GLP-1 ecnoglutide for weight loss
- [H3] J&J's Tecvayli claims third national priority FDA approval
- [H3] The GLP-1 Reckoning
- [H3] Alnylam bets on Tenaya RNAi tech, and other licensing news
- [H3] What US healthcare companies and medical researchers need to...
- [H3] What US healthcare companies and medical researchers need to...
- [H3] The GLP-1 Reckoning
- [H3] Using AI-driven synthetic personas to take your insights fur...
- [H3] AI in clinical development & ‘white space’, with Andrew Mack...
- [H3] New hope for ovarian cancer, with Alexander Schneider
- [H3] Expert Directed Applied Intelligence: Redefining AI in Life ...
- [H3] Editor's Picks
- [H3] China's clears Pfizer GLP-1 ecnoglutide for weight loss
- [H3] J&J's Tecvayli claims third national priority FDA approval
- [H3] Alnylam bets on Tenaya RNAi tech, and other licensing news
- [H3] Lilly unveils employer scheme for weight-loss drug Zepbound
- [H3] What US healthcare companies and medical researchers need to...
- [H3] JPM 2026: What it revealed about biotech’s new reality
- [H3] Pharma’s search loophole is a preview of what comes next
- [H3] Legacy data into living scientific memory
- [H3] The GLP-1 Reckoning
- [H3] GLP-1s: Five years that changed metabolic medicine
- [H3] Redesigning obesity trials for a chronic disease era
- [H3] The trust gap: GLP-1s and the new information economy of obe...
- [H3] Using AI-driven synthetic personas to take your insights fur...
- [H3] Expert Directed Applied Intelligence: Redefining AI in Life ...
- [H3] The strategic imperative of Integrated Evidence Generation P...
- [H3] Data managers and CRAs warn of rising data quality risks due...
- [H3] AI in clinical development & ‘white space’, with Andrew Mack...
- [H3] Collaboration & personalisation in rare disease R&D, with AO...
- [H3] Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al...
- [H3] On JPM2026 and healthcare investment today, with Jonah Comst...
- [H3] 7th Dermatology Drug Development Summit Europe
- [H3] The PM Society Launches Pharmony to Support More Effective P...
- [H3] EVERSANA Names Monica Avram Executive Vice President and Chi...
- [H3] Emerging Trends in Personalised Medicine at PHARMAP 2026
- [H3] Book your tickets and join the PM Society for the 40th PM Aw...
- [H5] header links
- [H5] Pharmaphorum menu first category
- [H5] SECTION
- [H5] Channels
- [H5] Channels
- [H5] SUB NAVIGATION
- [H5] US lawmakers take FDA to task over rare diseases record
- [H5] Gilead buys cell therapy partner Arcellx for up to $7.8bn
- [H5] What next for pharma as SCOTUS strikes down Trump tariffs?
- [H5] Novo Nordisk to cut GLP-1 prices in tough US market
- [H5] UK spurs prescribing of obesity jab Mounjaro with GP bonus
- [H5] Pharmaphorum Menu
Bilder
Es konnten 42 Bilder auf dieser Webseite gefunden werden.
Gut, denn die meisten Ihrer Bilder verwenden das ALT-Attribut.
Text/HTML Verhältnis
Anteil : 18%
Gut, denn das Text zu HTML Code Verhältnis dieser Webseite ist höher als 15, aber niedriger als 25 Prozent.
Flash
Perfekt, denn es wurde kein Flash auf Ihrer Webseite gefunden.
IFrame
Schlecht, denn Sie verwenden IFrames auf Ihrer Webseite, die von Suchmaschinen nicht indexiert werden können.
SEO Links
URL Rewrite
Gut. Ihre Links sind für Suchmaschinen gut lesbar (sprechende Links)!
Underscores in the URLs
Wir haben Unterstriche in Ihren Links entdeckt. Benutzen Sie zur Optimierung besser Bindestriche in Ihren Links.
In-page links
We found a total of 136 links including 1 link(s) to files
| Anker | Typ | Natürlich |
|---|---|---|
| Skip to main content | intern | natürliche Links |
| BlueSky | extern | natürliche Links |
| extern | natürliche Links | |
| youtube | extern | natürliche Links |
| Get Newsletters | intern | natürliche Links |
| Media Kit | intern | natürliche Links |
| News | intern | natürliche Links |
| Views & Analysis | intern | natürliche Links |
| Deep Dive | intern | natürliche Links |
| Equity and Sustainability | intern | natürliche Links |
| Research & Development | intern | natürliche Links |
| Market Access | intern | natürliche Links |
| Oncology | intern | natürliche Links |
| Artificial Intelligence | intern | natürliche Links |
| Patients & Partnerships | intern | natürliche Links |
| GLP-1 | intern | natürliche Links |
| Previous Editions | intern | natürliche Links |
| Webinars | intern | natürliche Links |
| Podcasts | intern | natürliche Links |
| Videos | intern | natürliche Links |
| Spotlight on | intern | natürliche Links |
| ASCO 2025 | intern | natürliche Links |
| BIO 2025 | intern | natürliche Links |
| C-Suite Innovators | intern | natürliche Links |
| ESMO 2025 | intern | natürliche Links |
| Frontiers Health 2025 | intern | natürliche Links |
| JP Morgan | intern | natürliche Links |
| Global Policy Insights | intern | natürliche Links |
| Events | intern | natürliche Links |
| close | extern | natürliche Links |
| Market Access | intern | natürliche Links |
| Oncology | intern | natürliche Links |
| Patients & Partnerships | intern | natürliche Links |
| Commercialisation | intern | natürliche Links |
| White Papers | intern | natürliche Links |
| Sales & Marketing | intern | natürliche Links |
| R&D | intern | natürliche Links |
| Digital | intern | natürliche Links |
| Market Access | intern | natürliche Links |
| Oncology | intern | natürliche Links |
| Patients | intern | natürliche Links |
| Live Coverage | intern | natürliche Links |
| Partner Content | intern | natürliche Links |
| About us | intern | natürliche Links |
| Contribute | intern | natürliche Links |
| Contact us | intern | natürliche Links |
| Sign in | intern | natürliche Links |
| China's clears Pfizer GLP-1 ecnoglutide for weight loss | intern | natürliche Links |
| J&J's Tecvayli claims third national priority FDA approval | intern | natürliche Links |
| The GLP-1 Reckoning | intern | natürliche Links |
| Alnylam bets on Tenaya RNAi tech, and other licensing news | intern | natürliche Links |
| What US healthcare companies and medical researchers need to... | intern | natürliche Links |
| Using AI-driven synthetic personas to take your insights fur... | intern | natürliche Links |
| AI in clinical development & ‘white space’, with Andrew Mack... | intern | natürliche Links |
| New hope for ovarian cancer, with Alexander Schneider | intern | natürliche Links |
| Expert Directed Applied Intelligence: Redefining AI in Life ... | intern | natürliche Links |
| US lawmakers take FDA to task over rare diseases record | intern | natürliche Links |
| Gilead buys cell therapy partner Arcellx for up to $7.8bn | intern | natürliche Links |
| What next for pharma as SCOTUS strikes down Trump tariffs? | intern | natürliche Links |
| Novo Nordisk to cut GLP-1 prices in tough US market | intern | natürliche Links |
| UK spurs prescribing of obesity jab Mounjaro with GP bonus | intern | natürliche Links |
| Subscribe | intern | natürliche Links |
| Lilly unveils employer scheme for weight-loss drug Zepbound | intern | natürliche Links |
| JPM 2026: What it revealed about biotech’s new reality | intern | natürliche Links |
| Pharma’s search loophole is a preview of what comes next | intern | natürliche Links |
| Legacy data into living scientific memory | intern | natürliche Links |
| GLP-1s: Five years that changed metabolic medicine | intern | natürliche Links |
| Redesigning obesity trials for a chronic disease era | intern | natürliche Links |
| The trust gap: GLP-1s and the new information economy of obe... | intern | natürliche Links |
| The strategic imperative of Integrated Evidence Generation P... | intern | natürliche Links |
| Data managers and CRAs warn of rising data quality risks due... | intern | natürliche Links |
| Collaboration & personalisation in rare disease R&D, with AO... | intern | natürliche Links |
| Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al... | intern | natürliche Links |
| On JPM2026 and healthcare investment today, with Jonah Comst... | intern | natürliche Links |
| 7th Dermatology Drug Development Summit Europe | intern | natürliche Links |
| The PM Society Launches Pharmony to Support More Effective P... | intern | natürliche Links |
| EVERSANA Names Monica Avram Executive Vice President and Chi... | intern | natürliche Links |
| Emerging Trends in Personalised Medicine at PHARMAP 2026 | intern | natürliche Links |
| Book your tickets and join the PM Society for the 40th PM Aw... | intern | natürliche Links |
| News | intern | natürliche Links |
| Views & Analysis | intern | natürliche Links |
| Deep Dive | intern | natürliche Links |
| Webinars | intern | natürliche Links |
| Podcasts | intern | natürliche Links |
| Video | intern | natürliche Links |
| White Papers | intern | natürliche Links |
| Event | intern | natürliche Links |
| News | intern | natürliche Links |
| Views & Analysis | intern | natürliche Links |
| Deep Dive | intern | natürliche Links |
| Webinars | intern | natürliche Links |
| Podcasts | intern | natürliche Links |
| Video | intern | natürliche Links |
| White Papers | intern | natürliche Links |
| Event | intern | natürliche Links |
| News | intern | natürliche Links |
| Views & Analysis | intern | natürliche Links |
| Deep Dive | intern | natürliche Links |
| Webinars | intern | natürliche Links |
| Podcasts | intern | natürliche Links |
| Video | intern | natürliche Links |
| White Papers | intern | natürliche Links |
| Event | intern | natürliche Links |
| News | intern | natürliche Links |
| Views & Analysis | intern | natürliche Links |
| Deep Dive | intern | natürliche Links |
| Webinars | intern | natürliche Links |
| Podcasts | intern | natürliche Links |
| Video | intern | natürliche Links |
| White Papers | intern | natürliche Links |
| Event | intern | natürliche Links |
| News | intern | natürliche Links |
| Views & Analysis | intern | natürliche Links |
| Deep Dive | intern | natürliche Links |
| Webinars | intern | natürliche Links |
| Podcasts | intern | natürliche Links |
| Video | intern | natürliche Links |
| White Papers | intern | natürliche Links |
| Event | intern | natürliche Links |
| News | intern | natürliche Links |
| Views & Analysis | intern | natürliche Links |
| Deep Dive | intern | natürliche Links |
| Webinars | intern | natürliche Links |
| Podcasts | intern | natürliche Links |
| Video | intern | natürliche Links |
| White Papers | intern | natürliche Links |
| Event | intern | natürliche Links |
| Axtria Ignite 2025 | intern | natürliche Links |
| Frontiers Health 2024 | intern | natürliche Links |
| Life Science Industry Report | intern | natürliche Links |
| World Without Disease Summit | intern | natürliche Links |
| Pharmaphorum | intern | natürliche Links |
| Cookie Policy | intern | natürliche Links |
| Privacy Policy | intern | natürliche Links |
| Terms & Conditions | intern | natürliche Links |
| Work for us | intern | natürliche Links |
SEO Suchbegriffe
Suchbegriffswolke
white sponsored healthcare news event content pharmaphorum glp-1 digital dive
Keywords Consistency
| Suchbegriff | Inhalt | Seitentitel | Suchbegriffe | Seitenbeschreibung | Überschriften |
|---|---|---|---|---|---|
| news | 17 |  |
 |
|
|
| white | 11 | |
|
|
|
| event | 10 | |
|
|
|
| healthcare | 9 | |
|
|
|
| content | 9 | |
|
|
|
Benutzerfreundlichkeit
URL
Domain : pharmaphorum.com
Länge : 16
Favoriten Icon
Gut. Die Webseite hat ein Favicon.
Druckeigenschaften
Es konnten keine druckfreundlichen CSS-Angaben gefunden werden.
Sprache
Gut, denn Sie haben in den META-Elementen eine Sprache deklariert: en.
Dublin Core
Diese Webseite nutzt nicht die Vorteile der Dublin Core Elemente.
Dokument
Doctype
HTML 5
Verschlüsselung
Perfekt, denn Ihre Webseite deklariert einen Zeichensatz: UTF-8.
W3C Validität
Fehler : 0
Warnungen : 0
E-Mail Datenschutz
Sehr gut, denn es wurde keine E-Mail Adresse im Klartext auf Ihrer Webseite gefunden.
Veraltetes HTML
Sehr gut! Sie verwenden aktuelle HTML Tags in Ihrem Webseitenquelltext.
Tipps zur Webseitengeschwindigkeit
|
Sehr gut, denn Ihre Webseite benutzt keine verschachtelten Tabellen. |
|
Schlecht, denn es wurden CSS-Angaben in HTML-Elementen entdeckt. Diese Angaben sollten in ein entsprechendes CSS-Stylesheet verlagert werden. |
|
Gut, denn Ihre Webseite enthält nur wenig CSS-Dateien. |
|
Nicht so gut, denn Ihre Webseite enthält viele Javascript-Dateien (mehr als 6). |
|
Gut! Sie nutzen die Vorteile von gzip. |
Mobile
Mobile Optimierung
|
Apple Icon |
|
META Viewport Tag |
|
Flash Inhalt |
Optimierung
XML-Sitemap
Perfekt! Ihre Seite hat eine XML-Sitemap.
| https://pharmaphorum.com/sitemap.xml |
Robots.txt
https://pharmaphorum.com/robots.txt
Sehr gut! Ihre Webseite enthält eine robots.txt-Datei.
Analytics
Sehr gut, Ihre Website hat ein Analyse-Tool.
Google Analytics |
PageSpeed Insights
Gerät
Kategorien
Free SEO Testing Tool
Free SEO Testing Tool ist ein kostenloses SEO Werkzeug zur Analyse Ihrer Webseite